Atypical G Protein β5 Promotes Cardiac Oxidative Stress, Apoptosis, and Fibrotic Remodeling in Response to Multiple Cancer Chemotherapeutics.
Sreemoyee Chakraborti,Arnab Pramanick,Sudipta Saha,Somnath Singha Roy,Arnab Ray Chaudhuri,Madhusudan Das,Sujoy Ghosh,Adele Stewart,Biswanath Maity,Biswanath Maity +9 more
TLDR
The experiments suggest that inhibition of Gβ5 might represent a novel means to circumvent cardiotoxicity in cancer patients whose treatment regimens include anthracyclines, taxanes, or fluoropyrimidines.Abstract:
The clinical use of multiple classes of cancer chemotherapeutics is limited by irreversible, dose-dependent, and sometimes life-threatening cardiotoxicity. Though distinct in their mechanisms of action, doxorubicin, paclitaxel, and 5-FU all induce rapid and robust upregulation of atypical G protein Gβ5 in the myocardium correlating with oxidative stress, myocyte apoptosis, and the accumulation of proinflammatory and profibrotic cytokines. In ventricular cardiac myocytes (VCM), Gβ5 deficiency provided substantial protection against the cytotoxic actions of chemotherapeutics, including reductions in oxidative stress and simultaneous attenuation of ROS-dependent activation of the ATM and CaMKII proapoptotic signaling cascades. In addition, Gβ5 loss allowed for maintenance of Δψm, basal mitochondrial calcium uniporter expression, and mitochondrial Ca2+ levels, effects likely to preserve functional myocyte excitation-contraction coupling. The deleterious effects of Gβ5 are not restricted to VCM, however, as Gβ5 knockdown also reduces chemotherapy-induced release of proinflammatory cytokines (e.g., TNFα), hypertrophic factors (e.g., ANP), and profibrotic factors (e.g., TGFβ1) from both VCM and ventricular cardiac fibroblasts, with the most dramatic reduction occurring in cocultured cells. Our experiments suggest that Gβ5 facilitates the myofibroblast transition, the persistence of which contributes to pathologic remodeling and heart failure. The convergence of Gβ5-mediated, ROS-dependent signaling pathways in both cell types represents a critical etiological factor in the pathogenesis of chemotherapy-induced cardiotoxicity. Indeed, intracardiac injection of Gβ5-targeted shRNA allowed for heart-specific protection against the damaging impact of chronic chemotherapy. Together, our results suggest that inhibition of Gβ5 might represent a novel means to circumvent cardiotoxicity in cancer patients whose treatment regimens include anthracyclines, taxanes, or fluoropyrimidines.Significance: These findings suggest that inhibiting an atypical G-protein might provide a strategy to limit the cardiotoxicity in cancer patients treated with anthracyclines, taxanes, or fluoropyrimidines. Cancer Res; 78(2); 528-41. ©2017 AACR.read more
Citations
More filters
Journal ArticleDOI
The role of the mitochondrial calcium uniporter (MCU) complex in cancer.
TL;DR: Current knowledge on the role of the mitochondrial calcium uniporter (MCU) complex in multiple cancer types and models is reviewed and a perspective for future research and clinical considerations is provided.
Journal ArticleDOI
Melatonin attenuates doxorubicin-induced cardiotoxicity through preservation of YAP expression
TL;DR: It is suggested that melatonin treatment attenuated doxorubicin‐induced cardiotoxicity through preserving YAP levels, which in turn decreases oxidative stress and apoptosis.
Journal ArticleDOI
Molecules and Mechanisms to Overcome Oxidative Stress Inducing Cardiovascular Disease in Cancer Patients.
Francesco Sabbatino,Valeria Conti,Luigi Liguori,Giovanna Polcaro,Graziamaria Corbi,Valentina Manzo,Vincenzo Tortora,Chiara Carlomagno,Carmine Vecchione,Amelia Filippelli,Stefano Pepe +10 more
TL;DR: In this paper, the role of ROS mediated oxidative stress mediated by oncological treatments in inducing cardiovascular disease was discussed and strategies that potentially counteract the oxidative stress in order to fight the onset and progression of cardiovascular disease.
Journal ArticleDOI
Polydatin protects against acute myocardial infarction-induced cardiac damage by activation of Nrf2/HO-1 signaling
TL;DR: In conclusion, polydatin effectively inhibited hypoxia- and AMI-induced myocardial damage by promotion of Nrf2/HO-1 signaling.
Journal ArticleDOI
Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats.
TL;DR: The beneficial effects of QL on DOX-induced CHF in rats are mediated by reduction in myocardial fibrosis, promotion of TGF-β3/Smad7, and inhibition of T GF-β1/ Smad3, which may also modulate specific miRNAs.
References
More filters
Journal ArticleDOI
Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression.
TL;DR: The finding that R GS6 is downregulated in all human breast cancer subtypes independent of their molecular classification indicates that obtaining a means to restore the growth suppressive and pro-apoptotic actions of RGS6 in breast might be a viable means to treat a large spectrum of breast tumors.
Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity
Hong Zhan,Kenichi Aizawa,Kenichi Aizawa,Junqing Sun,Shota Tomida,Shota Tomida,Kinya Otsu,Simon J. Conway,Peter J. McKinnon,Ichiro Manabe,Issei Komuro,Kiyoshi Miyagawa,Ryozo Nagai,Toru Suzuki +13 more
TL;DR: It is shown that ATM in cardiac fibroblasts is essential for Dox-induced cardiotoxicity, and antagonism of ATM and its functions may have potential therapeutic implications.
Journal ArticleDOI
Targeted deletion of one or two copies of the G protein β subunit Gβ5 gene has distinct effects on body weight and behavior in mice
Qiang Wang,Konstantin Levay,Tatyana Chanturiya,Galina Dvoriantchikova,Karen L. Anderson,Suzy D.C. Bianco,Cintia B. Ueta,R. Damaris Molano,Antonello Pileggi,Eugenia V. Gurevich,Oksana Gavrilova,Vladlen Z. Slepak +11 more
TL;DR: It is concluded that even a partial reduction in Gβ5‐R7 level can perturb normal animal metabolism and behavior, which may explain earlier observations of genetic linkage between R7 family mutations and obesity in humans.
Journal ArticleDOI
Gβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems
Keqiang Xie,Shencheng Ge,Victoria E. Collins,Christy L. Haynes,Kenneth J. Renner,Robert L. Meisel,Rafael Luján,Kirill A. Martemyanov,Kirill A. Martemyanov +8 more
TL;DR: These findings establish that Gβ5-RGS complexes are critical regulators of monoamine-NMDA receptor signaling cross-talk and link these complexes to disorders that manifest as hyperactivity, impaired learning, and motor dysfunctions.
Journal ArticleDOI
RGS6, but Not RGS4, Is the Dominant Regulator of G Protein Signaling (RGS) Modulator of the Parasympathetic Regulation of Mouse Heart Rate
TL;DR: RGS6-Gβ5, but not RGS4, is the primary RGS modulator of parasympathetic HR regulation and SAN M2R-IKACh signaling in mice, suggesting that the partial rescue of phenotypes in Rgs4+/−:Rgs6−/− mice is attributable to another R7 RGS protein whose influence on M2G protein signaling is masked by R GS4.